title: Angiotensin II-induced oxidative burst is fluvastatin sensitive in neutrophils of patients with hypercholesterolemia.
abstract: The aim of this study was to investigate the effect of the 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor fluvastatin (Flu) on angiotensin II (AII)-stimulated neutrophils of patients with hypercholesterolemia. Results suggest that a 6-week-long Flu administration completely counteracted the AII-induced increase in superoxide anion and leukotriene C4 production of the neutrophils of patients with hypercholesterolemia. However, the failure of signal processing through pertussis toxin-sensitive G protein, the increase in [Ca2+]i in membrane-bound protein kinase C activity, and the increase in neutrophil-bound cholesterol content were only partially restored by Flu. In addition, Flu had no effect on the increased membrane rigidity of the neutrophils of patients with hypercholesterolemia. To sum it up, Flu administration had a beneficial effect on AII-triggered reactive oxygen species generation; it resulted in partial restoration of signaling processes and of membrane composition, but membrane fluidity remained unchanged.
authors.affiliation: First Department of Medicine, Medical and Health Science Center, University of Debrecen, H-4012 Debrecen, Hungary.
authors.forename: Ildiko
authors.initials: I
authors.lastname: Seres
authors.forename: Gabriella
authors.initials: G
authors.lastname: Fóris
authors.forename: Dénes
authors.initials: D
authors.lastname: Páll
authors.forename: Béla
authors.initials: B
authors.lastname: Kosztáczky
authors.forename: Gyorgy
authors.initials: G
authors.lastname: Paragh
authors.forename: Zsuzsa
authors.initials: Z
authors.lastname: Varga
authors.forename: Gyorgy
authors.initials: G
authors.lastname: Paragh
mesh_terms: D000368:Aged; D000804:Angiotensin II / Q000494:pharmacology; D002118:Calcium / Q000378:metabolism; D002478:Cells, Cultured; D005229:Fatty Acids, Monounsaturated / Q000008:administration & dosage*; D000077340:Fluvastatin; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000494:pharmacology*; D006937:Hypercholesterolemia / Q000188:drug therapy* / Q000276:immunology*; D007211:Indoles / Q000008:administration & dosage*; D017997:Leukotriene C4 / Q000378:metabolism; D008297:Male; D008560:Membrane Fluidity / Q000187:drug effects; D008875:Middle Aged; D009504:Neutrophils / Q000166:cytology / Q000187:drug effects / Q000378:metabolism; D017382:Reactive Oxygen Species / Q000276:immunology / Q000378:metabolism; D016897:Respiratory Burst / Q000187:drug effects*; D015398:Signal Transduction / Q000187:drug effects; D014662:Vasoconstrictor Agents / Q000494:pharmacology
chemical_list: D005229:Fatty Acids, Monounsaturated; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D007211:Indoles; D017382:Reactive Oxygen Species; D014662:Vasoconstrictor Agents; D000804:Angiotensin II; D017997:Leukotriene C4; D000077340:Fluvastatin; D002118:Calcium